Clinical Trials Directory

Trials / Completed

CompletedNCT03699787

Graphomotor Intervention Program for Handwriting Difficulties Prevention in Preschool Age

The Effects of a Graphomotor Intervention Program According to a Psychomotor Approach on Graphomotor Competences in Preschool Children: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
University of Évora · Academic / Other
Sex
All
Age
5 Years – 5 Years
Healthy volunteers
Accepted

Summary

12-30% of children present handwriting difficulties, which has negative repercussions on their school career. For this reason, it is fundamental to bet on their prevention. The aim of present study is to examine the effects of a graphomotor intervention program on graphomotor competences in children in the last year of preschool education. This experimental study is a randomized controlled trial. The program will run for 8 weeks (2 sessions/week of 30 minutes), followed by 6 months of follow-up without intervention. Participants will be assessed 1) at baseline, 2) at the end of the program, and 3) after the follow-up. Participants will be randomly allocated to two groups: experimental group (graphomotor intervention program) and control group.

Detailed description

According to estimates, 12 to 30% of children have handwriting difficulties (1), which has negative consequences for school success (2). In addition, this is one of the main reasons for referral and consultation in psychomotricity in school-age (3), which reflects the urgency of acting in this field. The need for prevention and early intervention is indisputable (4). Several studies indicate that both outweigh the benefits of late intervention, because as time goes on it is increasingly difficult to correct handwriting difficulties (5-6). Graphomotor skills include the trait, the drawing and the formal handwriting and are related to long and complex learning, which requires several years of learning (7-9). Today it is known that preschool education represents a very important period for the development of these skills (10). In preschool, children spend 42% of the day on paper and pencil tasks (11) and it is during this period that handwriting readiness skills are developed (12), being a predictor of future school success (12-15). For Beery (16) children are not apt to learn to handwrite without first copying the first nine figures of the Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI). It is based on this that intervention programs have been developed with the aim of promoting the development of handwriting readiness skills in preschool age and of preventing possible handwriting difficulties at school age (14, 17). These intervention programs have shown favourable results in improving the graphomotor skills of preschool children (12, 17-18). In most cases only something is done, once the handwriting difficulties are installed. In addition, there are few studies dedicated to intervention in graphomotor skills at preschool age and to my knowledge, there is no study whose intervention is based on a psychomotor approach. Based on this, a graphomotor intervention program with a psychomotor approach was developed, by Matias and Vieira (19), who will apply in this study to children in the last year of preschool education.

Conditions

Interventions

TypeNameDescription
OTHERGraphomotor intervention programThe graphomotor intervention program aims to promote the development and reinforcement, different skills involved in the learning process of handwriting and has a preventive character. It follows a bodily, playful, multisensory, exploratory (sensory integration) and neuromotor task training approach and focuses on the following intervention domains: segmental awareness, passive relaxation, trunk-limb dissociation, interdigital coordination, attention, planning, spatial organization/orientation and perception.

Timeline

Start date
2018-10-15
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2018-10-09
Last updated
2020-03-27

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT03699787. Inclusion in this directory is not an endorsement.